NDC properties for NDC 9 72606-022
NDC item 72606002209
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-09 |
| NDC Item | 72606002209 |
| packaging | 1 SYRINGE in 1 CARTON (72606-022-09) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
NDC item 72606002210
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-10 |
| NDC Item | 72606002210 |
| packaging | 2 SYRINGE in 1 CARTON (72606-022-10) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
NDC item 72606002211
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-11 |
| NDC Item | 72606002211 |
| packaging | 4 SYRINGE in 1 CARTON (72606-022-11) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
NDC item 72606002212
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-12 |
| NDC Item | 72606002212 |
| packaging | 6 SYRINGE in 1 CARTON (72606-022-12) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |